CVRx | Barostim

📍 Minneapolis, United States🗓 Founded 2001👥 225 employees💰 Last funded May 2016
CVRx is a commercial stage, public (NASDAQ: CVRX) medical devices company located in Minneapolis, Minnesota. The company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. Barostim™ triggers carotid baroreceptors - the body’s own natural blood flow regulation system - which signals the brain to regulate cardiovascular function. Patient Stories on CVRx: The accounts and quotes of patients are genuine and documented. These stories represent a unique individual experience and does not provide any indication, guide, warranty or guarantee as to the response other people may have to CVRx technologies. Barostim is a prescriptive device. For a list of all potential benefits and risks go to www.cvrx.com/benefit-risk-analysis/
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2001
Founded
Investor geography2 countries
United States
1
Spain
1
Frequently asked questions
Who invested in CVRx | Barostim?
CVRx | Barostim has 2 investors on record on gritt.io.
When did CVRx | Barostim last raise funding?
The most recent investment in CVRx | Barostim recorded on gritt.io was in May 2016.
When was CVRx | Barostim founded?
CVRx | Barostim was founded in 2001.
What industry is CVRx | Barostim in?
CVRx | Barostim operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is CVRx | Barostim based?
CVRx | Barostim is headquartered in Minneapolis, United States.